Abstract
The Sec13 protein functions in various intracellular compartments including the nuclear pore complex, COPII-coated vesicles, and inside the nucleus as a transcription regulator. Here we developed a mouse model that expresses low levels of Sec13 (Sec13H/-) to assess its functions in vivo, as Sec13 knockout is lethal. These Sec13 mutant mice did not present gross defects in anatomy and physiology. However, the reduced levels of Sec13 in vivo yielded specific immunological defects. In particular, these Sec13 mutant mice showed low levels of MHC I and II expressed by macrophages, low levels of INF-γ and IL-6 expressed by stimulated T cells, and low frequencies of splenic IFN-γ+CD8+ T cells. In contrast, the levels of soluble and membrane-bound TGF-β as well as serum immunoglobulin production are high in these mice. Furthermore, frequencies of CD19+CD5-CD95+ and CD19+CD5-IL-4+B cells were diminished in Sec13H/- mice. Upon stimulation or immunization, some of the defects observed in the naïve mutant mice were compensated. However, TGF-β expression remained high suggesting that Sec13 is a negative modulator of TGF-β expression and of its immunosuppressive functions on certain immune cells. In sum, Sec13 regulates specific expression of immune factors with key functions in inflammation.
Original language | English |
---|---|
Article number | 17655 |
Journal | Scientific Reports |
Volume | 5 |
DOIs | |
State | Published - 3 Dec 2015 |
Bibliographical note
Funding Information:We thank the Electron Microscopy Facility and Metabolic Core Facility at UT Southwestern for TEM studies and biochemical measurements, respectively. Funding was provided by NIH R01 GM113874-01, R01 AI079110, R01 AI089539, CPRIT RP121003-RP120718-P2 to B.F; Israel Science Foundation (1072/10) to A.H.; NIH GM096070 to J.S.; Fellowship from CNPq Brasil to A.M.C.F. and Scholarship from FAPEMIG Brasil to T.G.M.
Funding
We thank the Electron Microscopy Facility and Metabolic Core Facility at UT Southwestern for TEM studies and biochemical measurements, respectively. Funding was provided by NIH R01 GM113874-01, R01 AI079110, R01 AI089539, CPRIT RP121003-RP120718-P2 to B.F; Israel Science Foundation (1072/10) to A.H.; NIH GM096070 to J.S.; Fellowship from CNPq Brasil to A.M.C.F. and Scholarship from FAPEMIG Brasil to T.G.M.
Funders | Funder number |
---|---|
National Institutes of Health | R01 AI079110, R01 GM113874-01 |
National Institute of Allergy and Infectious Diseases | R01AI089539 |
Cancer Prevention and Research Institute of Texas | RP121003-RP120718-P2 |
Conselho Nacional de Desenvolvimento Científico e Tecnológico | |
Israel Science Foundation | GM096070, 1072/10 |
Fundação de Amparo à Pesquisa do Estado de Minas Gerais |